The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 10
  • 1
    Smirnyagina, Ekaterina, Dr
    Senior Partner, Oxford Science Enterprises born in August 1966
    Individual (3 offsprings)
    Officer
    2024-11-25 ~ now
    OF - Director → CIF 0
  • 2
    Wisniewski, Raphael
    Blank born in April 1970
    Individual (1 offspring)
    Officer
    2018-03-29 ~ now
    OF - Director → CIF 0
  • 3
    Peakman, Marie-claire
    Principal Pfizer Ventures (Biotech Investing) born in July 1969
    Individual (3 offsprings)
    Officer
    2022-12-23 ~ now
    OF - Director → CIF 0
  • 4
    Joyce, Peter
    Director born in April 1982
    Individual (1 offspring)
    Officer
    2017-09-29 ~ now
    OF - Director → CIF 0
  • 5
    Nasrallah, Rabab
    Investment Professional born in August 1986
    Individual (1 offspring)
    Officer
    2022-12-23 ~ now
    OF - Director → CIF 0
  • 6
    Johnson, Emma
    Director born in June 1996
    Individual (5 offsprings)
    Officer
    2022-12-23 ~ now
    OF - Director → CIF 0
  • 7
    Hercend, Thierry, Dr
    Blank born in March 1952
    Individual (1 offspring)
    Officer
    2018-03-29 ~ now
    OF - Director → CIF 0
  • 8
    Mccarthy, Thomas David
    Company Director born in June 1967
    Individual (10 offsprings)
    Officer
    2017-09-29 ~ now
    OF - Director → CIF 0
  • 9
    Weightman, Tracy
    Investor born in November 1979
    Individual (2 offsprings)
    Officer
    2024-05-15 ~ now
    OF - Director → CIF 0
  • 10
    Ahrens, Brenton Karl
    Blank born in March 1963
    Individual (3 offsprings)
    Officer
    2018-03-29 ~ now
    OF - Director → CIF 0
Ceased 7
  • 1
    Dewhurst, Sally Marianne, Dr.
    Biotech Investor born in March 1990
    Individual (2 offsprings)
    Officer
    2022-12-23 ~ 2024-11-25
    OF - Director → CIF 0
  • 2
    Onions, Stuart Thomas
    Director born in July 1979
    Individual (3 offsprings)
    Officer
    2018-03-18 ~ 2018-03-29
    OF - Director → CIF 0
  • 3
    Mr Peter Joyce
    Born in April 1982
    Individual (1 offspring)
    Person with significant control
    2017-09-29 ~ 2018-03-29
    PE - Ownership of shares – More than 50% but less than 75%CIF 0
    PE - Ownership of voting rights - More than 50% but less than 75%CIF 0
    PE - Right to appoint or remove directorsCIF 0
  • 4
    Harris, Samantha Ann
    Individual (3 offsprings)
    Officer
    2022-06-22 ~ 2025-03-01
    OF - Secretary → CIF 0
  • 5
    Thomas David Mccarthy
    Born in June 1967
    Individual (10 offsprings)
    Person with significant control
    2017-09-29 ~ 2018-03-29
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
  • 6
    2765, Sand Hill Rd, Menlo Park, California, United States
    Corporate
    Person with significant control
    2019-02-12 ~ 2019-02-12
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
  • 7
    374, Rue Saint-honore, Paris, 75001, France
    Corporate
    Person with significant control
    2019-02-12 ~ 2019-02-12
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
parent relation
Company in focus

GREY WOLF THERAPEUTICS LIMITED

Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Average Number of Employees
182023-01-01 ~ 2023-12-31
142022-01-01 ~ 2022-12-31
Property, Plant & Equipment
57,111 GBP2023-12-31
77,503 GBP2022-12-31
Fixed Assets - Investments
5 GBP2023-12-31
5 GBP2022-12-31
Fixed Assets
57,116 GBP2023-12-31
77,508 GBP2022-12-31
Debtors
Current
6,606,933 GBP2023-12-31
1,413,201 GBP2022-12-31
Cash at bank and in hand
9,031,259 GBP2023-12-31
9,568,847 GBP2022-12-31
Current Assets
15,638,192 GBP2023-12-31
10,982,048 GBP2022-12-31
Creditors
Current, Amounts falling due within one year
-2,329,021 GBP2023-12-31
-928,661 GBP2022-12-31
Net Current Assets/Liabilities
13,309,171 GBP2023-12-31
10,053,387 GBP2022-12-31
Net Assets/Liabilities
13,366,287 GBP2023-12-31
10,130,895 GBP2022-12-31
Equity
Called up share capital
1,557 GBP2023-12-31
1,092 GBP2022-12-31
843 GBP2022-01-01
Share premium
52,225,802 GBP2023-12-31
33,086,571 GBP2022-12-31
22,959,179 GBP2022-01-01
Capital redemption reserve
3 GBP2023-12-31
3 GBP2022-12-31
2 GBP2022-01-01
Retained earnings (accumulated losses)
-38,861,075 GBP2023-12-31
-22,956,771 GBP2022-12-31
-16,806,522 GBP2022-01-01
Equity
13,366,287 GBP2023-12-31
10,130,895 GBP2022-12-31
6,153,502 GBP2022-01-01
Profit/Loss
Retained earnings (accumulated losses)
-15,904,304 GBP2023-01-01 ~ 2023-12-31
-6,150,248 GBP2022-01-01 ~ 2022-12-31
Profit/Loss
-15,904,304 GBP2023-01-01 ~ 2023-12-31
-6,150,248 GBP2022-01-01 ~ 2022-12-31
Issue of Equity Instruments
Called up share capital
465 GBP2023-01-01 ~ 2023-12-31
250 GBP2022-01-01 ~ 2022-12-31
Issue of Equity Instruments
19,139,696 GBP2023-01-01 ~ 2023-12-31
10,127,642 GBP2022-01-01 ~ 2022-12-31
Property, Plant & Equipment - Gross Cost
Office equipment
48,803 GBP2023-12-31
45,623 GBP2022-12-31
Computers
46,499 GBP2023-12-31
24,255 GBP2022-12-31
Other
77,556 GBP2023-12-31
77,556 GBP2022-12-31
Property, Plant & Equipment - Gross Cost
172,858 GBP2023-12-31
147,434 GBP2022-12-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
Office equipment
21,005 GBP2022-12-31
Computers
15,496 GBP2022-12-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
69,931 GBP2022-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Office equipment, Owned/Freehold
13,424 GBP2023-01-01 ~ 2023-12-31
Computers, Owned/Freehold
10,958 GBP2023-01-01 ~ 2023-12-31
Owned/Freehold
45,816 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Office equipment
34,429 GBP2023-12-31
Computers
26,454 GBP2023-12-31
Other
54,864 GBP2023-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
115,747 GBP2023-12-31
Property, Plant & Equipment
Office equipment
14,374 GBP2023-12-31
24,618 GBP2022-12-31
Computers
20,045 GBP2023-12-31
8,759 GBP2022-12-31
Other
22,692 GBP2023-12-31
44,126 GBP2022-12-31
Amounts Owed by Group Undertakings
Current
424,990 GBP2023-12-31
42,582 GBP2022-12-31
Other Debtors
Current
3,923,864 GBP2023-12-31
228,787 GBP2022-12-31
Prepayments/Accrued Income
Current
197,231 GBP2023-12-31
89,420 GBP2022-12-31
Amount of corporation tax that is recoverable
Current
2,060,848 GBP2023-12-31
1,052,412 GBP2022-12-31
Trade Creditors/Trade Payables
Current
1,337,066 GBP2023-12-31
650,530 GBP2022-12-31
Taxation/Social Security Payable
Current
268,684 GBP2023-12-31
62,253 GBP2022-12-31
Other Creditors
Current
7,049 GBP2023-12-31
473 GBP2022-12-31
Accrued Liabilities/Deferred Income
Current
716,222 GBP2023-12-31
215,405 GBP2022-12-31
Creditors
Current
2,329,021 GBP2023-12-31
928,661 GBP2022-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
1,688,528 shares2023-12-31
1,687,061 shares2022-12-31
Par Value of Share
Class 1 ordinary share
0.00012023-01-01 ~ 2023-12-31
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
3,597,122 shares2023-12-31
3,597,122 shares2022-12-31
Par Value of Share
Class 2 ordinary share
0.00012023-01-01 ~ 2023-12-31
Number of Shares Issued (Fully Paid)
Class 3 ordinary share
691,755 shares2023-12-31
691,755 shares2022-12-31
Par Value of Share
Class 3 ordinary share
0.00012023-01-01 ~ 2023-12-31
Number of Shares Issued (Fully Paid)
Class 4 ordinary share
2,454,223 shares2023-12-31
2,454,223 shares2022-12-31
Par Value of Share
Class 4 ordinary share
0.00012023-01-01 ~ 2023-12-31

  • GREY WOLF THERAPEUTICS LIMITED
    Info
    Registered number 10989365
    99 Park Drive, Milton, Abingdon OX14 4RY
    Private Limited Company incorporated on 2017-09-29 (7 years 9 months). The company status is Active.
    The last date of confirmation statement was made at 2024-10-27
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.